GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-737 Cr | ₹-769 Cr | ₹-561 Cr | ₹-1,543 Cr | ₹-524 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-737 Cr |
| Mar2025 | ₹-769 Cr |
| Mar2024 | ₹-561 Cr |
| Mar2023 | ₹-1,543 Cr |
| Mar2022 | ₹-524 Cr |
How is Cash Flow from Financing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-737 Cr | Negative | |
| Mar2025 | ₹-769 Cr | Negative | |
| Mar2024 | ₹-561 Cr | Negative | |
| Mar2023 | ₹-1,543 Cr | Negative | |
| Mar2022 | ₹-524 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹46,185.2 Cr | 9% | 7.7% | 4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 9% |
7.7% |
4.2% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses